About the Company
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on AGENUS INC
Agenus Inc ( NASDAQ:AGEN ) Estimates Trends - Yahoo Finance
Agenus Inc (NASDAQ:AGEN) is set to release its Q1 2025 earnings on May 12, 2025. The consensus estimate for Q1 2025 revenue is $26.38 million, and the earnings are expected to come in at -$1.66 ...
Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress
Agenus Inc. ("Agenus" or the "Company") (Nasdaq: AGEN), an immuno-oncology company focused on innovation, today reports ...
Agenus: Taking Advantage Of The Risk-Reward Opportunity
Agenus Inc. has unveiled promising data from the NEST-1 study, showing the potential of the combination of botensilimab and balstilimab in colorectal cancer treatment.
Agenus To Host BOT/BAL Program Update at ESMO 2023
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced that the Company will host a corporate ...
Agenus Inc. (AGEN) Q4 2024 Earnings Call Transcript
Agenus Inc. (NASDAQ:AGEN) Q4 2024 Earnings Conference Call March 11, 2025 8:30 AM ETCompany ParticipantsZack Armen - Head of Investor Relations, Corporate ...
Agenus Inc. Faces Ongoing Risks: What Investors Need to Know
Agenus Inc. (AGEN) has disclosed a new risk, in the Regulation category.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data ...
Why Agenus Inc. Stock Sank in December
10 stocks we like better than Agenus When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool ...
November 5 Deadline: Agenus Inc Is Being Sued For Defrauding The Public ...
LOS ANGELES, CA / ACCESSWIRE / November 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Agenus Inc. ("Agenus" or ...
Agenus' (AGEN) Pipeline Progression on Track Amid Competition
We issued an updated research report on Agenus Inc. AGEN on May 23, 2019. Agenus has collaboration agreements with a number of companies, which not only provide it with funds in the form of ...
Analysts Have Just Cut Their Agenus Inc. (NASDAQ:AGEN) Revenue ...
Today is shaping up negative for Agenus Inc. (NASDAQ:AGEN) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. Revenue estimates were cut sharply ...
Why Shares of Agenus Inc. Rose 10.1% on Tuesday
The company has a promising colon cancer therapy.What happened Agenus (AGEN -2.49%) opened at $2.65 then rose to a high of $2.93 in the early afternoon. The stock has a 52-week low of $1.25 and a ...
Similar Companies
Loading the latest forecasts...